GOODWILL AND ACQUIRED INTANGIBLES

3 Months Ended

Mar. 31, 2026

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL

Goodwill

Goodwill is tested annually for impairment, unless certain triggering events require an interim impairment analysis, including macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, and other relevant entity-specific events and changes. These considerations are evaluated holistically to assess whether it is more likely than not that a reporting unit's carrying value exceeds its fair value. As of March 31, 2026, the Bridg platform is considered a discontinued operation and therefore, is no longer a reporting unit. Our reporting units consist of the Cardlytics platform in the U.S. (the "U.S. Cardlytics Platform"), and the Cardlytics platform in the U.K. There is no goodwill recorded within the Cardlytics platform in the U.K.

The carrying amounts of goodwill as of March 31, 2026 were as follows (in thousands):


	U.S. Cardlytics Platform		Consolidated
Balance as of December 31, 2025	$	110,305	$	110,305
Impairment charge	—		—
Balance as of March 31, 2026	$	110,305	$	110,305

We have assessed the triggering event criteria, along with related conditions and developments, as of March 31, 2026. We continue to monitor our results and the price of our common stock in relation to goodwill impairment. Based on our qualitative analysis for the first quarter of 2026, we have determined that none of the conditions collectively constitute a triggering event. As such, we have determined that it is not more likely than not that the carrying values of our reporting units exceed their respective fair values, and an impairment test was not required as of March 31, 2026. However, the Cardlytics platform in the U.S. is susceptible to future impairment risk, and future changes in assumptions or deterioration in market conditions could result in an impairment.